» Articles » PMID: 37397478

Natural Compounds Targeting Mitochondrial Dysfunction: Emerging Therapeutics for Target Organ Damage in Hypertension

Overview
Journal Front Pharmacol
Date 2023 Jul 3
PMID 37397478
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension generally causes target organ damage (TOD) in the heart, brain, kidney, and blood vessels. This can result in atherosclerosis, plaque formation, cardiovascular and cerebrovascular events, and renal failure. Recent studies have indicated that mitochondrial dysfunction is crucial in hypertensive target organ damage. Consequently, mitochondria-targeted therapies attract increasing attention. Natural compounds are valuable resources for drug discovery and development. Many studies have demonstrated that natural compounds can ameliorate mitochondrial dysfunction in hypertensive target organ damage. This review examines the contribution of mitochondrial dysfunction to the development of target organ damage in hypertension. Moreover, it summarizes therapeutic strategies based on natural compounds that target mitochondrial dysfunction, which may be beneficial for preventing and treating hypertensive target organ damage.

Citing Articles

Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.

Belenichev I, Popazova O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Suprun E Antioxidants (Basel). 2025; 14(1).

PMID: 39857442 PMC: 11760872. DOI: 10.3390/antiox14010108.


Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma.

Hatawsh A, Al-Haddad R, Okafor U, Diab L, Dekanoidze N, Abdulwahab A Med Oncol. 2024; 41(12):302.

PMID: 39465473 DOI: 10.1007/s12032-024-02538-8.


Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks.

Taghdiri A Egypt Heart J. 2024; 76(1):71.

PMID: 38849680 PMC: 11161443. DOI: 10.1186/s43044-024-00506-1.

References
1.
Cui L, Li Z, Chang X, Cong G, Hao L . Quercetin attenuates vascular calcification by inhibiting oxidative stress and mitochondrial fission. Vascul Pharmacol. 2016; 88:21-29. DOI: 10.1016/j.vph.2016.11.006. View

2.
Zhang J, Chen Y, Luo H, Sun L, Xu M, Yu J . Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin. Front Pharmacol. 2018; 9:1204. PMC: 6209623. DOI: 10.3389/fphar.2018.01204. View

3.
Doughan A, Harrison D, Dikalov S . Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2007; 102(4):488-96. DOI: 10.1161/CIRCRESAHA.107.162800. View

4.
Ikemura M, Sasaki Y, Giddings J, Yamamoto J . Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats. Phytother Res. 2012; 26(9):1272-7. DOI: 10.1002/ptr.3724. View

5.
Hu Y, Chen M, Liang D . Lignans and terpenoids from Gaultheria leucocarpa var. yunnanensis and their anti-inflammatory and antioxidant activities. Fitoterapia. 2022; 162:105293. DOI: 10.1016/j.fitote.2022.105293. View